Request Demo
Last update 29 Aug 2025
Zhejiang Raygene Pharmaceuticals Co., Ltd
Private Company|2019|Zhejiang Sheng, China
Private Company|2019|Zhejiang Sheng, China
Last update 29 Aug 2025
Overview
Tags
Digestive System Disorders
Neoplasms
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
NCT06844357
A Multi-center, Randomized, Controlled, Open-label Phase II/III Clinical Trial to Investigate Whether Transarterial Tirapazamine Injection Followed by Transarterial Embolization (TATE) is Superior to Traditional Transarterial Chemoembolization (TACE) in Patients With Intermediate-Stage Hepatocellular Carcinoma (HCC)
NCT06834399
Phase IIA Clinical Trial of Intra-arterial Administration of Tirapazamine Followed by Transarterial Embolization （TATE）and KN046 for the Treatment of Advanced Colorectal Cancer with Liver Metastasis (MSS/pMMR)
CTR20230034
经肝动脉注射替拉扎明再行肝动脉栓塞（TATE）与KN046联合治疗晚期肝转移性结直肠癌（MSS/ pMMR）的IIA期临床试验
[Translation] A phase IIA clinical trial of transarterial tirapazamine followed by hepatic arterial embolization (TATE) combined with KN046 in the treatment of advanced liver metastatic colorectal cancer (MSS/pMMR)
100 Clinical Results associated with Zhejiang Raygene Pharmaceuticals Co., Ltd
Login to view more data
Login to view more data
100 Deals associated with Zhejiang Raygene Pharmaceuticals Co., Ltd
Login to view more data
100 Translational Medicine associated with Zhejiang Raygene Pharmaceuticals Co., Ltd
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 31 Oct 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3
1
1
Other
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free